Austar Lifesciences Ltd. is an investment holding company, which engages in the provision of engineering solutions to pharmaceutical manufacturers and research institutes. The company is headquartered in Shanghai, Shanghai and currently employs 1,446 full-time employees. The company went IPO on 2014-11-07. The firm operates six segments: Fluid and Bioprocess Systems segment, Cleanroom and Automation Control and Monitoring Systems segment, Powder and Solid Systems segment, GMP Compliance Services segment, Life Science Consumables segment, and Distribution and Agency of Pharmaceutical Equipment segment. The firm's products include clean utility equipment and systems, bioprocess equipment and systems, powder and solid equipment and systems, pharmaceutical process contamination control products, packaging and closed transport products, biosafety and laboratory animal equipment and consumables, and others.
